Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 204
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Pα+ Psychedelic Bulletin #212: Delix Posts Early Efficacy Signal; NRx Wants FDA to Ban Competitors’ Ketamine; Cybin Raises $175M
Q3’25 Psychedelic Lobbying Update
Jennifer Espenscheid — Art as a Practice, Psychedelics as a Teacher
The Psychedelic News Feed: October 20 – 26, 2025
Pα+ Psychedelic Bulletin #211: AbbVie Officially Enters Psychedelics; atai-Beckley’s 5-MeO-DMT Scores Breakthrough Therapy Designation; California Bill Signed
PT273 – Erica Rex – Clinical Trials and Spontaneous Mystical Experiences
MindMed Launches Study of Low-Dose LSD Effects on Sleep and Cognitive...
MindMed Announces Financial Results for the Third Quarter 2021 and Business...
atai Life Sciences Reports Third Quarter 2021 Financial Results and Corporate...
Filament Health Reports Third Quarter 2021 Financial Results and Operational Highlights
Field Trip Health Ltd. Reports Second Fiscal Quarter 2022 Financial Results...
Discussions With FDA Provide Guidance for Phase IIb Clinical Trial Design...
Red Light Holland Psilocybin Truffles, Sold in The Netherlands, Complete First...
Psychedelic Bulletin: Deconstructing COMPASS Pathways’ Phase 2b Results
PharmaTher Announces Positive Research Results for Psilocybin Microneedle Patch
1
...
203
204
205
...
300
Page 204 of 300